Gmo Equity Ten Year Return vs. Net Asset

GMUEX Fund  USD 13.77  0.09  0.65%   
Based on the key profitability measurements obtained from Gmo Equity's financial statements, Gmo Equity Allocation may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess Gmo Equity's ability to earn profits and add value for shareholders.
For Gmo Equity profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Gmo Equity to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Gmo Equity Allocation utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Gmo Equity's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Gmo Equity Allocation over time as well as its relative position and ranking within its peers.
  
Check out Risk vs Return Analysis.
Please note, there is a significant difference between Gmo Equity's value and its price as these two are different measures arrived at by different means. Investors typically determine if Gmo Equity is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Gmo Equity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Gmo Equity Allocation Net Asset vs. Ten Year Return Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Gmo Equity's current stock value. Our valuation model uses many indicators to compare Gmo Equity value to that of its competitors to determine the firm's financial worth.
Gmo Equity Allocation is one of the top funds in ten year return among similar funds. It also is one of the top funds in net asset among similar funds making up about  88,372,882  of Net Asset per Ten Year Return. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Gmo Equity's earnings, one of the primary drivers of an investment's value.

Gmo Net Asset vs. Ten Year Return

Ten Year Return shows the total annualized return generated from holding a fund for the last 10 years and represents fund's capital appreciation, including dividends losses and capital gains distributions. This return indicator is considered by many investors to be the ultimate measures of fund performance and can reflect the overall performance of the market or market segment it invests in.

Gmo Equity

Ten Year Return

 = 

(Mean of Monthly Returns - 1)

X

100%

 = 
11.19 %
Although Ten Year Fund Return indicator can give a sense of overall fund long-term potential, it is recommended to compare funds performances against other similar funds or market benchmarks for the same 10-year interval.
Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.

Gmo Equity

Net Asset

 = 

Current Market Value

-

Current Liabilities

 = 
988.89 M
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.

Gmo Net Asset Comparison

Gmo Equity is currently under evaluation in net asset among similar funds.

Gmo Equity Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Gmo Equity, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Gmo Equity will eventually generate negative long term returns. The profitability progress is the general direction of Gmo Equity's change in net profit over the period of time. It can combine multiple indicators of Gmo Equity, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Under normal circumstances, the fund invests directly and indirectly at least 80 percent of its assets in equities tied economically to the United States. It also may invest in U.S. Treasury fund, in money market funds unaffiliated with GMO, and directly in the types of investments typically held by money market funds.

Gmo Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Gmo Equity. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Gmo Equity position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Gmo Equity's important profitability drivers and their relationship over time.

Use Gmo Equity in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Gmo Equity position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gmo Equity will appreciate offsetting losses from the drop in the long position's value.

Gmo Equity Pair Trading

Gmo Equity Allocation Pair Trading Analysis

The ability to find closely correlated positions to Gmo Equity could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Gmo Equity when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Gmo Equity - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Gmo Equity Allocation to buy it.
The correlation of Gmo Equity is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Gmo Equity moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Gmo Equity Allocation moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Gmo Equity can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Gmo Equity position

In addition to having Gmo Equity in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Warren Buffett Holdings Thematic Idea Now

Warren Buffett Holdings
Warren Buffett Holdings Theme
A long-term portfolio of publicly-traded stocks on US exchanges that are owned by Warren Buffett's holding company Berkshire Hathaway. The Warren Buffett Holdings theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Warren Buffett Holdings Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Gmo Mutual Fund

To fully project Gmo Equity's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Gmo Equity Allocation at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Gmo Equity's income statement, its balance sheet, and the statement of cash flows.
Potential Gmo Equity investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Gmo Equity investors may work on each financial statement separately, they are all related. The changes in Gmo Equity's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Gmo Equity's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.